• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[免疫组化检测胸腔积液和支气管标本中p53蛋白的临床意义。]

[Clinical significance of immunohistochemical detection of p53 protein in pleural effusion and bronchial specimen.].

作者信息

Wang J, Jiang Y, He A

机构信息

Pathology Department of No.202 Hospital of PLA, Shenyang 110003, P.R.China.

出版信息

Zhongguo Fei Ai Za Zhi. 1998 Jul 10;1(1):40-1. doi: 10.3779/j.issn.1009-3419.1998.01.11.

DOI:10.3779/j.issn.1009-3419.1998.01.11
PMID:20863463
Abstract

BACKGROUND

To explore the usefulness of p53 immunohistochemical staining as a marker of malignancy in the diagnosis of lung cancer.

METHODS

The expression of p53 in 57 samples of pleural effusion and 69 bronchial biopsy specimens was investigated by immunohistochemical method.

RESULTS

p53 was well preserved in the samples of pleural effusion. p53 positive rate was 0%(0/27) ,33.3 %(2/6) and 54.2%(13/24) respectively in cytologically benign , suspicious but not conclusively malignant and malignant pleural effusion. Benign pleural effusion referred as tuberculous and other inflammatory effusion. p53 poisitive rate was 0%(0/23) ,14.3 %(1/7) and 35.9 % (14/39) in histologically benign , atypical proliferating and malignant bronchial biopsy sample. The cases with p53 immunoreactivity were proved to have lung cancer after follow-up in cytologically suspicious but not conclusively malignant pleural effusion and histologically atypical proliferating bronchial biopsy sample.

CONCLUSIONS

p53 immunostaining could be useful as a marker of malignancy in the cytologic examination of pleural effusion and bronchial biopsy sample. The presence of p53 immunoreactivity in these samples is strongly suggestive of malignancy , though its absence does not exclude neoplasms.

摘要

背景

探讨p53免疫组化染色作为肺癌诊断中恶性肿瘤标志物的实用性。

方法

采用免疫组化方法研究57例胸腔积液样本和69例支气管活检标本中p53的表达情况。

结果

胸腔积液样本中p53保存良好。在细胞学检查为良性、可疑但不能确诊为恶性以及恶性胸腔积液中,p53阳性率分别为0%(0/27)、33.3%(2/6)和54.2%(13/24)。良性胸腔积液指结核性及其他炎性积液。在组织学检查为良性、非典型增生及恶性支气管活检样本中,p53阳性率分别为0%(0/23)、14.3%(1/7)和35.9%(14/39)。在细胞学检查可疑但不能确诊为恶性的胸腔积液以及组织学检查非典型增生的支气管活检样本中,经随访,p53免疫反应阳性的病例被证实患有肺癌。

结论

p53免疫染色可作为胸腔积液和支气管活检样本细胞学检查中恶性肿瘤的标志物。这些样本中存在p53免疫反应强烈提示恶性肿瘤,但其缺失并不排除肿瘤的存在。

相似文献

1
[Clinical significance of immunohistochemical detection of p53 protein in pleural effusion and bronchial specimen.].[免疫组化检测胸腔积液和支气管标本中p53蛋白的临床意义。]
Zhongguo Fei Ai Za Zhi. 1998 Jul 10;1(1):40-1. doi: 10.3779/j.issn.1009-3419.1998.01.11.
2
p53 immunostaining as a marker of malignancy in cytologic preparations of body fluids.p53免疫染色作为体液细胞涂片检查中恶性肿瘤的标志物
Acta Cytol. 1995 Mar-Apr;39(2):171-6.
3
Positive effusion cytology as the initial presentation of malignancy.阳性积液细胞学检查作为恶性肿瘤的初始表现。
Acta Cytol. 1987 Jul-Aug;31(4):448-52.
4
[Clinical evaluation and tissue distribution of CA125 in patients with pleural effusion].[胸腔积液患者CA125的临床评估及组织分布]
Igaku Kenkyu. 1989 Nov;59(3):90-6.
5
The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.CDKN2A缺失作为体腔积液中恶性间皮瘤诊断标志物的应用。
Cancer. 2003 Feb 25;99(1):51-6. doi: 10.1002/cncr.10923.
6
[Expressions of 8-OH-dG, k-ras, and p53 genes in pleural effusion cells and their clinical significances].[8-羟基脱氧鸟苷、k-ras和p53基因在胸腔积液细胞中的表达及其临床意义]
Ai Zheng. 2005 Mar;24(3):345-8.
7
[A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].[用于恶性间皮瘤、累及胸膜的非小细胞癌及良性反应性间皮细胞增生鉴别诊断的免疫组化标志物的比较评估]
Pneumonol Alergol Pol. 2007;75(1):57-69.
8
p53 gene product in pleural effusions. Practical use in distinguishing benign from malignant cells.胸腔积液中的p53基因产物。在鉴别良性与恶性细胞中的实际应用。
Acta Cytol. 1996 Sep-Oct;40(5):855-60. doi: 10.1159/000333991.
9
[The role of pleural effusion cytology in the diagnosis of malignancies].[胸腔积液细胞学检查在恶性肿瘤诊断中的作用]
Plucne Bolesti. 1989 Jul-Dec;41(3-4):146-9.
10
A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases.为确保胸腔积液充分引流,需要的最小液体量为 75 毫升:2540 例回顾性分析。
Cancer Cytopathol. 2014 Sep;122(9):657-65. doi: 10.1002/cncy.21452. Epub 2014 Jul 24.